Absolute Antibody Ltd. has announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain of SARS-CoV-2.

LabVantage has announced that the newly released 8.5 edition of its LabVantage platform offers a fully integrated Scientific Data Management System (SDMS, ensuring security and control against data loss or modification.

Horizon Discovery has announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines to help accelerate gene knockout and gene activation experiments, respectively.

Centogene and the OESIS Network have announced a partnership for COVID-19 screening of schools. The partnership will offer RT-PCR testing that can aid schools in their return to campus in the fall and continued screening to prevent a resurgence of COVID-19 over the course of the academic school year.

Cancer Research UK and Abcam plc have announced a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

TALLC has announced that the United Kingdom Intellectual Property Office (IPO) has granted the first in a series of SmartCelle smart micelle patents covering their novel nanotechnology for ocular drug delivery.

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

Vetter and Rentschler Biopharma have announced their strategic collaboration to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.

The Express Scanner from Ziath is a rapid solution for ensuring the traceability of samples in 2D-barcoded nuclear magnetic resonance (NMR) tubes.

osteolabs GmbH has announced further validation and clinical evidence for the use of OsteoTest for the early detection of bone loss.